Posters presented at the 2025 American Academy of Dermatology Annual Meeting found tildrakizumab outcomes to have a mean drug ...
LEO Pharma and Reig Jofre have entered into a partnership aimed at improving access to LEO’s psoriasis treatment in Europe.
Troy Casey doesn’t mind the taste, calling it “hair of the dog” — but several experts have shared warnings about his “direct biofeedback loop.” ...
Inquirer Opinion on MSN1d
Lifelong itch
My first experience with the condition was in my third year in high school. It started as subtle red bumps along my hairline, ...
Your feet can tell you about underlying health-related issues before symptoms appear anywhere else. Therefore, you must not ...
Prime Biome is a synergistic supplement bridging advanced probiotics (like B. coagulans) with potent botanicals (Babchi, ...
a skin disorder like psoriasis, or a hormonal disorder like thyroid disease. While many nail ridges are harmless and pose no risk to your health, those that develop suddenly, affect many nails, or are ...
A panelist discusses how new data from the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) demonstrates tildrakizumab’s efficacy in treating nail psoriasis, with the 100-mg dose showing ...
A systematic review revealed that patients with psoriasis have a significantly higher prevalence of onychomycosis than those without psoriasis.
Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...
According to board-certified dermatologist with MDCS Dermatology, Dr. Brendan Camp, this is because urea is both a humectant ...
The increased risk may be due to inflammation caused by an autoimmune response to PsA or psoriasis. Read on to learn more about PsA and the risk of developing some neurological conditions if you ...